Cannabis as Medicine

Contaminants in cannabis and hemp flowers create potential for health risks.

Team of researchers urges further study and evaluation of standards for medical use. Date: October 20, 2023 Source: University of Tennessee Institute of Agriculture Summary: Cannabis use, even for medical purposes, could make some people sick due to harmful fungi that contaminate the plants. That is the finding of a recently published peer-reviewed journal article, whose authors recommend further […]

Contaminants in cannabis and hemp flowers create potential for health risks. Read More »

Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies

(Summary:  the following demographics should completely ABSTAIN from cannabis use: People aged 0-28 years of age (children and adolescents – developing brain) Pregnant women People with mental illness or vulnerable to such Drivers/Driving (one could also assume, anyone operating a vehicle of any kind) Whilst there are only some minor benefits from some cannabis derivatives,

Balancing risks and benefits of cannabis use: umbrella review of meta-analyses of randomised controlled trials and observational studies Read More »

Cannabis deleterious Impact on Proper Neurodevelopment of Foetus: Emerging Roles of Endocannabinoids as Key Lipid Mediators for a Successful Pregnancy

 Int. J. Mol. Sci. 2023, 24(6), 5220; https://doi.org/10.3390/ijms24065220 In recent years, Cannabis use/misuse for treating pregnancy-related symptoms and other chronic conditions has increased among pregnant women, favored by decriminalization and/or legalization of its recreational uses in addition to its easy accessibility. However, there is evidence that prenatal Cannabis exposure might have adverse consequences on pregnancy progression and a deleterious impact on proper

Cannabis deleterious Impact on Proper Neurodevelopment of Foetus: Emerging Roles of Endocannabinoids as Key Lipid Mediators for a Successful Pregnancy Read More »

Victorian government to trial the impacts of medicinal cannabis use on driving – Hmm, but who is overseeing the trial, and outcomes will emerge?

Channel 7 released news on State governments Cannabis and Driving Trials…“It is currently illegal for residents to drive while under the influence of THC, the main psychoactive chemical in marijuana. Victorian medicinal cannabis users will be put through a closed-track trial to see when it’s safe for them to get behind the wheel. The 18-month trial will look

Victorian government to trial the impacts of medicinal cannabis use on driving – Hmm, but who is overseeing the trial, and outcomes will emerge? Read More »

Cannabis Use & Perinatal Health Research (JAMA)

…in utero cannabis exposure is linked to adverse outcomes among offspring, including small for gestational age, neonatal intensive care unit admissions, and preterm birth. In addition, prenatal cannabis exposure has also been associated with childhood outcomes such as autism spectrum disorder and attention-deficit/hyperactivity disorder, as well as symptoms of psychopathology, including psychotic like experiences, internalizing,

Cannabis Use & Perinatal Health Research (JAMA) Read More »

Cannabis- and Substance-Related Carcinogenesis in Europe: A Lagged Causal Inferential Panel Regression Study

(From) Abstract: Recent European data facilitate an epidemiological investigation of the controversial cannabis–cancer relationship. Of particular concern were prior findings associating high-dose cannabis use with reproductive problems and potential genetic impacts… Cannabis is a more important carcinogen than tobacco and alcohol and fulfills epidemiological qualitative and quantitative criteria for causality for 25/41 cancers. Reproductive and transgenerational

Cannabis- and Substance-Related Carcinogenesis in Europe: A Lagged Causal Inferential Panel Regression Study Read More »

Cannabis and Cannabinoids for Pain and Posttraumatic Stress Disorder in Military Personnel and Veterans (The Cannabis Placebo Factor in Play Agai

Cannabis and Cannabinoids for Pain and Posttraumatic Stress Disorder in Military Personnel and Veterans (The Cannabis Placebo Factor in Play Again) Implications and Conclusions: The current body of evidence does not support the use of cannabis or cannabinoids for the treatment of pain or PTSD in military personnel or veterans. The favorable outcomes that patients report with

Cannabis and Cannabinoids for Pain and Posttraumatic Stress Disorder in Military Personnel and Veterans (The Cannabis Placebo Factor in Play Agai Read More »

Only Three Cannabinoid Based Medicines Have FDA approval HHC is not one of them. 

What Is HHC? Hexahydrocannabinol, or “HHC,” is a cannabinoid, which are naturally occurring compounds in cannabis plants. Scientists have found more than 100 cannabinoids. The most commonly known cannabinoids are Delta-9 THC and cannabidiol (CBD). THC is the ingredient in marijuana that makes you feel high. Cannabidiol is the ingredient in many CBD products that claim to help with

Only Three Cannabinoid Based Medicines Have FDA approval HHC is not one of them.  Read More »

Comparison of Health Care Providers Attitudes and Beliefs Regarding Medical Marijuana and Cannabidiol in the Management of Pain and Other Symptoms in Cancer Patients

Published Online:31 Mar 2023 https://doi.org/10.1089/jpm.2022.0433 Abstract Background: Medical marijuana (MM) and cannabidiol (CBD) have received increasing attention to manage pain and other symptoms even with limited scientific evidence. Objectives: We examined the attitudes and beliefs of health care providers toward MM and CBD compared to standard treatments for cancer-associated pain and various symptoms. Design: Two sets of anonymous surveys

Comparison of Health Care Providers Attitudes and Beliefs Regarding Medical Marijuana and Cannabidiol in the Management of Pain and Other Symptoms in Cancer Patients Read More »

The impact of timing of in utero marijuana exposure on foetal growth

Objective: To examine whether timing of in utero marijuana exposure independently and negatively impacts fetal growth, and if these effects are global or specific to certain growth parameters Conclusions: Timing of marijuana exposure appears to play a key role in specific fetal growth deficits, with exposure throughout gestation most detrimental. However even first trimester exposure may result

The impact of timing of in utero marijuana exposure on foetal growth Read More »

Scroll to Top